Influenza Vaccines for the World – IVW 2012 is the fourth international conference and exhibition in this important series after meetings held in 2004, 2006 and most recently in Cannes in April 2009 during the H1N1 pandemic scare. The IVW conference series focuses on ‘Influenza Vaccination Issues’ and is designed to complement the other two major influenza meetings in the conference calendar: ESWI and the Options for Control of Influenza.
The IVW series is an international forum for world renowned experts in the field of influenza vaccines and related issues (adjuvants/delivery/vaccination strategies) to report on the latest data and trends associated with current and new influenza vaccines/technologies and their availability/delivery/implementation worldwide.
The IVW 2012 Scientific Advisory Panel invites the influenza community worldwide to submit poster abstracts for consideration for inclusion in the IVW 2012 poster scientific programmes.
IVW 2012 Pre-Conference One Day Symposium
Influenza Control – The Five Pillars:
Antivirals, Antibodies, Vaccines, Immunomodulatory Treatments & Non-Pharmaceutical Interventions
Tuesday 9th October 2012, Palacio de Congresos De Valencia, Valencia, Spain
Symposium Chair: Professor John Oxford (Retroscreen Virology Ltd, London, UK)
The ongoing threat of an outbreak of pandemic influenza , whether it be H1N1 or a variant virus, has focused leading scientists attention on the planning and usage of the Five Pillars: a cocktail of antiviral drugs, vaccines, antibodies, immunomodulatory treatments and other non-pharmaceutical interventions in combination to mitigate and counter such an event.
This pre-conference one day symposium will offer a programme of presentations from leading world experts on the use of the ‘Five Pillars’ and their combined strategies that will be employed in the face of a worldwide influenza pandemic as well as the annual seasonal influenza programmes.
IVW 2012 Scientific Advisory Panel
Nancy Cox (CDC, Atlanta, Georgia, USA)
Klaus Stöhr (Novartis Vaccines, Cambridge, Massachusetts, USA)
Othmar Engelhardt (NIBSC/HPA, Potters Bar, UK)
Eric Desauziers (Sanofi-Pasteur, Lyon, France)
John Oxford (St Barts & London, UK)
Martin Meltzer (CDC, Atlanta, Georgia, USA)
Albert Osterhaus (Erasmus University, Rotterdam, The Netherlands)
Gregory Glenn (Novavax Inc., Rockville, Maryland, USA)
Ted Ross (University of Pittsburgh, Pennsylvania, USA)
Yoshihiro Kawaoka (University of Wisconsin, Madison, Wisconsin, USA)
Kathy Coelingh (MedImmune, Mountain View, California, USA)
Otfried Kistner (Baxter Innovations, Vienna, Austria)
Jonathan Van Tam (University of Nottingham, UK)
Rob Lambkin-Williams (Retroscreen Virology Ltd, London, UK)
Jim Robertson (NIBSC/HPA, Potters Bar, UK)
Dirk Polaert (GSK Biologicals, Rixensart, Belgium)
Ronald Kompier (FluConsult, Noordwijk, The Netherlands)
Emma Ball (CSL Biotherapies, Parkville, Victoria, Australia)
IVW 2012 will address the following important topics:
- Surveillance Issues / Burden of Disease
- Immunological Issues
- Social / Political / Financial Issues Surrounding Influenza Vaccination
- Novel Developments
- Production / Formulation Issues / Manufacturing Issues
- Vaccine Usage / Targeting Strategies
- Influenza Vaccines / Adjuvants – Improvement Issues
- Pandemic Preparedness Issues / Licensing Issues
The scientific programme will include keynote lectures, contributed papers, workshops, panel discussions, satellite symposia and poster presentations emphasising all aspects of ‘Influenza Vaccines’ and their usage and effectiveness. Potential authors are invited to submit abstracts on any of the above topics for consideration for inclusion within the conference program.
5th European Influenza Conference
Organized by the European Scientific Working Group on Influenza. ESWI unites influenza experts of different disciplines from all over Europe, in the aim to combat the impact of epidemic and pandemic influenza.
More information on the venue and the programme soon to be found on www.eswiconference.org